---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-331113"
form_type: "8-K"
ticker: "SNSE"
cik: "0001829802"
company_name: "Sensei Biotherapeutics, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:17:15.299408+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Sensei Bio sets CEO salary at $425K, SVP at $400K; retention bonuses tied to Feb 2026

## Summary
- Annual base salaries: Christopher Gerry $425,000, Josiah Craver $400,000, effective Nov 14, 2025.
- Each eligible for target annual bonus equal to 40% of base salary beginning FY 2026.
- First retention bonus equals full 2025 target bonus if employed through Feb 13, 2026 or terminated without cause.
- Second retention bonus is prorated 2026 target bonus if terminated without cause before 2026 bonus payment; 2x multiplier if not change-in-control.
- Severance benefits require execution of separation agreement and release of claims.

## SEC filing metadata
- accession: 0001193125-25-331113
- form_type: 8-K
- ticker: SNSE
- cik: 0001829802
- company_name: Sensei Biotherapeutics, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829802/000119312525331113/0001193125-25-331113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829802/000119312525331113/d68669d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-331113
- JSON: https://secwatch.observer/filing/0001193125-25-331113.json
- Plain text: https://secwatch.observer/filing/0001193125-25-331113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.